Please enable JavaScript to continue using this application.

Compare $ELDN vs $IVVD | Chartloom

Compare

$ELDN vs $IVVD

Eledon Pharmaceuticals Inc · Invivyd Inc

ELDN

Eledon Pharmaceuticals Inc

IVVD

Invivyd Inc

Compare $ELDN vs $IVVD

Comparing Eledon Pharmaceuticals Inc and Invivyd Inc

ELDNEledon Pharmaceuticals Inc

IVVDInvivyd Inc

ELDNEledon Pharmaceuticals Inc

Market cap

$191M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

53.1%

52W performance

-13.6%

FCF yield

-38.6%

IVVDInvivyd Inc

Market cap

$212M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

3.13x

Rev growth (TTM)

26.3%

YTD performance

-71.2%

52W performance

-56.0%

FCF yield

-51.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ELDN

IVVD

Detailed metrics comparison

ELDN

Eledon Pharmaceuticals Inc

IVVD

Invivyd Inc

Market Cap

ELDN$191M

IVVD$212M

Enterprise Value

ELDN$185M

IVVD$52M

Price

ELDN$2.48

IVVD$0.72

P/E Ratio

ELDNN/A

IVVDN/A

P/S Ratio

ELDN0.00x

IVVD3.64x

EV/Sales

ELDN0.00x

IVVD0.90x

EV/EBITDA

ELDN0.00x

IVVD0.00x

P/B Ratio

ELDN2.81x

IVVD1.34x

P/FCF Ratio

ELDNN/A

IVVDN/A

EV/FCF

ELDN-2.50x

IVVD-0.48x

PEG Ratio

ELDNN/A

IVVDN/A

Forward P/E (NTM)

ELDNN/A

IVVDN/A

Forward P/S (NTM)

ELDNN/A

IVVD3.13x

Revenue (TTM)

ELDN$0

IVVD$58M

Revenue Growth (YoY)

ELDNN/A

IVVD26.3%

Forward Rev Growth

ELDN325.8%

IVVD44.8%

Gross Margin (TTM)

ELDN0.0%

IVVD92.2%

Operating Margin (TTM)

ELDN0.0%

IVVD0.0%

EBITDA Margin (TTM)

ELDN0.0%

IVVD-191.7%

Net Margin (TTM)

ELDN0.0%

IVVD-183.9%

FCF Margin (TTM)

ELDNN/A

IVVD-187.9%

Net Income (TTM)

ELDN$-99M

IVVD$-107M

FCF (TTM)

ELDN$-74M

IVVD$-110M

EPS (TTM)

ELDN-$0.87

IVVD-$0.33

ROE (TTM)

ELDN-9848.0%

IVVD-5973.0%

ROA (TTM)

ELDN-6897.0%

IVVD-4897.0%

ROIC (TTM)

ELDN-9848.0%

IVVD-5973.0%

Cash

ELDN$7M

IVVD$160M

Debt

ELDN$0

IVVD$0

Net Cash/Debt

ELDN$7M

IVVD$160M

Current Ratio (TTM)

ELDN7.90x

IVVD5.87x

Quick Ratio (TTM)

ELDN7.60x

IVVD5.60x

Debt/Equity (TTM)

ELDN0.00x

IVVD0.00x

Debt/Assets (TTM)

ELDN0.0%

IVVD0.0%

Interest Coverage (TTM)

ELDNN/A

IVVDN/A

Net Debt/EBITDA (TTM)

ELDN0.00x

IVVD0.00x

Beta

ELDN1.01

IVVD1.32

52W Performance

ELDN-13.6%

IVVD-56.0%

YTD Performance

ELDN53.1%

IVVD-71.2%

% from 52W High

ELDN-46.1%

IVVD-76.5%

% from 52W Low

ELDN83.7%

IVVD36.7%

Asset Turnover (TTM)

ELDN0.00x

IVVD0.27x

FCF Yield (TTM)

ELDN-38.6%

IVVD-51.6%

Earnings Yield (TTM)

ELDN-51.5%

IVVD-50.5%

Dividend Yield (TTM)

ELDNN/A

IVVDN/A

Rule of 40

ELDN0.0

IVVD-161.6

EV/GP/RG

ELDNN/A

IVVD0.06

Ticker research

View ELDN research View IVVD research

Metric	ELDN Eledon Pharmaceuticals Inc	IVVD Invivyd Inc
Market & Valuation
Market Cap	$191M	$212M
Enterprise Value	$185M	$52M
Price	$2.48	$0.72
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	3.64x
EV/Sales	0.00x	0.90x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.81x	1.34x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.50x	-0.48x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	3.13x
Revenue & Growth
Revenue (TTM)	$0	$58M
Revenue Growth (YoY)	N/A	26.3%
Forward Rev Growth	325.8%	44.8%
Profitability
Gross Margin (TTM)	0.0%	92.2%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-191.7%
Net Margin (TTM)	0.0%	-183.9%
FCF Margin (TTM)	N/A	-187.9%
Net Income (TTM)	$-99M	$-107M
FCF (TTM)	$-74M	$-110M
EPS (TTM)	-$0.87	-$0.33
ROE (TTM)	-9848.0%	-5973.0%
ROA (TTM)	-6897.0%	-4897.0%
ROIC (TTM)	-9848.0%	-5973.0%
Financial Health
Cash	$7M	$160M
Debt	$0	$0
Net Cash/Debt	$7M	$160M
Current Ratio (TTM)	7.90x	5.87x
Quick Ratio (TTM)	7.60x	5.60x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.01	1.32
52W Performance	-13.6%	-56.0%
YTD Performance	53.1%	-71.2%
% from 52W High	-46.1%	-76.5%
% from 52W Low	83.7%	36.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.27x
FCF Yield (TTM)	-38.6%	-51.6%
Earnings Yield (TTM)	-51.5%	-50.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-161.6
EV/GP/RG	N/A	0.06
Ticker research	View ELDN research	View IVVD research

Valuation

P/S Ratio

ELDN

0.00x

IVVD

3.64x

EV/FCF

ELDN

-2.50x

IVVD

-0.48x

Growth & revenue

Revenue Growth TTM

IVVD

26.3%

Forward Revenue Growth

ELDN

325.8%

IVVD

44.8%

Profitability & performance

Gross Margin

IVVD

92.2%

ELDN

0.0%

ROE

IVVD

-5973.0%

ELDN

-9848.0%

FCF Yield %

ELDN

-38.6%

IVVD

-51.6%

52-Week Performance

ELDN

-13.6%

IVVD

-56.0%

Detailed metrics comparison

ELDN

Eledon Pharmaceuticals Inc

IVVD

Invivyd Inc

Market Cap

ELDN$191M

IVVD$212M

Enterprise Value

ELDN$185M

IVVD$52M

Price

ELDN$2.48

IVVD$0.72

P/E Ratio

ELDNN/A

IVVDN/A

P/S Ratio

ELDN0.00x

IVVD3.64x

EV/Sales

ELDN0.00x

IVVD0.90x

EV/EBITDA

ELDN0.00x

IVVD0.00x

P/B Ratio

ELDN2.81x

IVVD1.34x

P/FCF Ratio

ELDNN/A

IVVDN/A

EV/FCF

ELDN-2.50x

IVVD-0.48x

PEG Ratio

ELDNN/A

IVVDN/A

Forward P/E (NTM)

ELDNN/A

IVVDN/A

Forward P/S (NTM)

ELDNN/A

IVVD3.13x

Revenue (TTM)

ELDN$0

IVVD$58M

Revenue Growth (YoY)

ELDNN/A

IVVD26.3%

Forward Rev Growth

ELDN325.8%

IVVD44.8%

Gross Margin (TTM)

ELDN0.0%

IVVD92.2%

Operating Margin (TTM)

ELDN0.0%

IVVD0.0%

EBITDA Margin (TTM)

ELDN0.0%

IVVD-191.7%

Net Margin (TTM)

ELDN0.0%

IVVD-183.9%

FCF Margin (TTM)

ELDNN/A

IVVD-187.9%

Net Income (TTM)

ELDN$-99M

IVVD$-107M

FCF (TTM)

ELDN$-74M

IVVD$-110M

EPS (TTM)

ELDN-$0.87

IVVD-$0.33

ROE (TTM)

ELDN-9848.0%

IVVD-5973.0%

ROA (TTM)

ELDN-6897.0%

IVVD-4897.0%

ROIC (TTM)

ELDN-9848.0%

IVVD-5973.0%

Cash

ELDN$7M

IVVD$160M

Debt

ELDN$0

IVVD$0

Net Cash/Debt

ELDN$7M

IVVD$160M

Current Ratio (TTM)

ELDN7.90x

IVVD5.87x

Quick Ratio (TTM)

ELDN7.60x

IVVD5.60x

Debt/Equity (TTM)

ELDN0.00x

IVVD0.00x

Debt/Assets (TTM)

ELDN0.0%

IVVD0.0%

Interest Coverage (TTM)

ELDNN/A

IVVDN/A

Net Debt/EBITDA (TTM)

ELDN0.00x

IVVD0.00x

Beta

ELDN1.01

IVVD1.32

52W Performance

ELDN-13.6%

IVVD-56.0%

YTD Performance

ELDN53.1%

IVVD-71.2%

% from 52W High

ELDN-46.1%

IVVD-76.5%

% from 52W Low

ELDN83.7%

IVVD36.7%

Asset Turnover (TTM)

ELDN0.00x

IVVD0.27x

FCF Yield (TTM)

ELDN-38.6%

IVVD-51.6%

Earnings Yield (TTM)

ELDN-51.5%

IVVD-50.5%

Dividend Yield (TTM)

ELDNN/A

IVVDN/A

Rule of 40

ELDN0.0

IVVD-161.6

EV/GP/RG

ELDNN/A

IVVD0.06

Ticker research

View ELDN research View IVVD research

Metric	ELDN Eledon Pharmaceuticals Inc	IVVD Invivyd Inc
Market & Valuation
Market Cap	$191M	$212M
Enterprise Value	$185M	$52M
Price	$2.48	$0.72
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	3.64x
EV/Sales	0.00x	0.90x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.81x	1.34x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.50x	-0.48x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	3.13x
Revenue & Growth
Revenue (TTM)	$0	$58M
Revenue Growth (YoY)	N/A	26.3%
Forward Rev Growth	325.8%	44.8%
Profitability
Gross Margin (TTM)	0.0%	92.2%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-191.7%
Net Margin (TTM)	0.0%	-183.9%
FCF Margin (TTM)	N/A	-187.9%
Net Income (TTM)	$-99M	$-107M
FCF (TTM)	$-74M	$-110M
EPS (TTM)	-$0.87	-$0.33
ROE (TTM)	-9848.0%	-5973.0%
ROA (TTM)	-6897.0%	-4897.0%
ROIC (TTM)	-9848.0%	-5973.0%
Financial Health
Cash	$7M	$160M
Debt	$0	$0
Net Cash/Debt	$7M	$160M
Current Ratio (TTM)	7.90x	5.87x
Quick Ratio (TTM)	7.60x	5.60x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.01	1.32
52W Performance	-13.6%	-56.0%
YTD Performance	53.1%	-71.2%
% from 52W High	-46.1%	-76.5%
% from 52W Low	83.7%	36.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.27x
FCF Yield (TTM)	-38.6%	-51.6%
Earnings Yield (TTM)	-51.5%	-50.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-161.6
EV/GP/RG	N/A	0.06
Ticker research	View ELDN research	View IVVD research